C1QTNF6 and breast cancer: Further analyses focused on the correlation between C1QTNF6 expression and clinical characteristics of BC patients indicated that high C1QTNF6 expression was more prominent in advanced TM status as well as pathological and AJCC stages when compared with the low-expression group.